Hepregen
Biotechnology company that focuses on understanding the metabolism of drugs in the liver.
Launch date
Employees
Market cap
-
Enterprise valuation
$12—18m (Dealroom.co estimates Sep 2008.)
Medford Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$3.0m | Series A | ||
N/A | $50.0k | Grant | |
$500k | Grant | ||
$500k | Grant | ||
N/A | $500k | Grant | |
Total Funding | $4.5m |
Related Content
Recent News about Hepregen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.